Jump to content

Nirsevimab: Revision history


For any version listed below, click on its date to view it. For more help, see Help:Page history and Help:Edit summary. (cur) = difference from current version, (prev) = difference from preceding version, m = minor edit, → = section edit, ← = automatic edit summary

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

12 October 2024

  • curprev 17:2717:27, 12 October 2024 185.113.22.54 talk 24,666 bytes +79 Research: The page stated that nirsevimab is a vaccine, and cited reference no. 10. It is actually not a vaccine, and the reference 10 states that clearly: "Nirsevimab is designed to provide RSV protection via an antibody given directly to an infant to help prevent LRTI caused by RSV, unlike active immunization, where a person’s immune system is activated to prevent or fight infection through a vaccine" undo Tags: Mobile edit Mobile web edit

21 September 2024

27 August 2024

10 March 2024

7 March 2024

7 February 2024

4 January 2024

3 January 2024

2 January 2024

20 December 2023

12 December 2023

27 November 2023

20 November 2023

8 November 2023

2 November 2023

8 October 2023

5 October 2023

20 August 2023

19 August 2023

11 August 2023

8 August 2023

7 August 2023

19 July 2023

4 May 2023

24 April 2023

13 April 2023

4 March 2023

25 January 2023

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)